Search research articles
Contact Us
Filters
Showing results (721-730 of 986) with videos related to
Page
of 99
Sort By:
Assay and Drug Development Technologies
|
April 20, 2004
A high throughput screening assay to screen for CYP2E1 metabolism and inhibition using a fluorogenic vivid p450 substrate
Bryan D Marks, Ronald W Smith, Heidi A Braun, et al.
Biosensors & Bioelectronics
|
August 1, 2009
Quantum dot immunoassays in renewable surface column and 96-well plate formats for the fluorescence detection of botulinum neurotoxin using high-affinity antibodies
Marvin G Warner, Jay W Grate, Abby Tyler, et al.
Analytical Chemistry
|
June 18, 2009
Rapid multiplexed flow cytometric assay for botulinum neurotoxin detection using an automated fluidic microbead-trapping flow cell for enhanced sensitivity
Richard M Ozanich, Cynthia J Bruckner-Lea, Marvin G Warner, et al.
Journal of Immunological Methods
|
June 9, 2004
Novel application of an in vitro technique to the detection and quantification of botulinum neurotoxin antibodies
Yper H J Hall, John A Chaddock, Hilary J Moulsdale, et al.
British Journal of Haematology
|
September 1, 1994
Characterization of human blood group scFv antibodies derived from a V gene phage-display library
N C Hughes-Jones, B D Gorick, J M Bye, et al.
Transplantation
|
July 24, 2012
Distribution of ABO blood group antibody titers in pediatric patients awaiting renal transplantation: implications for organ allocation policy
A Nicholas R Barnett, Alex Hudson, Vassilis G Hadjianastassiou, et al.
Nature Biotechnology
|
December 19, 2006
Molecular evolution of antibody cross-reactivity for two subtypes of type A botulinum neurotoxin
Consuelo Garcia-Rodriguez, Raphael Levy, Joseph W Arndt, et al.
Nephron
|
September 21, 2017
UK Renal Registry 19th Annual Report: Chapter 9 Clinical, Haematological and Biochemical Parameters in Patients on Renal Replacement Therapy in Paediatric Centres in the UK in 2015: National and Centre-specific Analyses
Alexander J Hamilton, Fiona Braddon, Anna Casula, et al.
Pediatric Nephrology (Berlin, Germany)
|
September 18, 2017
Clinical risk stratification of paediatric renal transplant recipients using C1q and C3d fixing of de novo donor-specific antibodies
Jon Jin Kim, Olivia Shaw, Chloe Martin, et al.
Nature Communications
|
June 23, 2026
A belt-buckle checkpoint regulates the onset of botulinum neurotoxin intoxication
Baohua Chen, Linfeng Gao, Melvin Bönninger, et al.
Page
of 99
Search research articles
Search
Showing results (721-730 of 986) with videos related to
Sort By:
Page
of 99
Assay and Drug Development Technologies
|
April 20, 2004
A high throughput screening assay to screen for CYP2E1 metabolism and inhibition using a fluorogenic vivid p450 substrate
Bryan D Marks, Ronald W Smith, Heidi A Braun, et al.
Biosensors & Bioelectronics
|
August 1, 2009
Quantum dot immunoassays in renewable surface column and 96-well plate formats for the fluorescence detection of botulinum neurotoxin using high-affinity antibodies
Marvin G Warner, Jay W Grate, Abby Tyler, et al.
Analytical Chemistry
|
June 18, 2009
Rapid multiplexed flow cytometric assay for botulinum neurotoxin detection using an automated fluidic microbead-trapping flow cell for enhanced sensitivity
Richard M Ozanich, Cynthia J Bruckner-Lea, Marvin G Warner, et al.
Journal of Immunological Methods
|
June 9, 2004
Novel application of an in vitro technique to the detection and quantification of botulinum neurotoxin antibodies
Yper H J Hall, John A Chaddock, Hilary J Moulsdale, et al.
British Journal of Haematology
|
September 1, 1994
Characterization of human blood group scFv antibodies derived from a V gene phage-display library
N C Hughes-Jones, B D Gorick, J M Bye, et al.
Transplantation
|
July 24, 2012
Distribution of ABO blood group antibody titers in pediatric patients awaiting renal transplantation: implications for organ allocation policy
A Nicholas R Barnett, Alex Hudson, Vassilis G Hadjianastassiou, et al.
Nature Biotechnology
|
December 19, 2006
Molecular evolution of antibody cross-reactivity for two subtypes of type A botulinum neurotoxin
Consuelo Garcia-Rodriguez, Raphael Levy, Joseph W Arndt, et al.
Nephron
|
September 21, 2017
UK Renal Registry 19th Annual Report: Chapter 9 Clinical, Haematological and Biochemical Parameters in Patients on Renal Replacement Therapy in Paediatric Centres in the UK in 2015: National and Centre-specific Analyses
Alexander J Hamilton, Fiona Braddon, Anna Casula, et al.
Pediatric Nephrology (Berlin, Germany)
|
September 18, 2017
Clinical risk stratification of paediatric renal transplant recipients using C1q and C3d fixing of de novo donor-specific antibodies
Jon Jin Kim, Olivia Shaw, Chloe Martin, et al.
Nature Communications
|
June 23, 2026
A belt-buckle checkpoint regulates the onset of botulinum neurotoxin intoxication
Baohua Chen, Linfeng Gao, Melvin Bönninger, et al.
Page
of 99